Oriol Mirallas MD· @DrMirallas · X·· 2026-04-19评分60
正文
暂无中文译文，显示英文原文。
#AACR26
Educational session: chemistry to clinic, next-gen #ADC
Dr. Wang
Kinase inhibitors ADC #PI3K #HER2
New approach
Efficacy of #PI3K inhibitor #Comp3
Pertuzumab backbone
DAR 6
Completely new approach
Targeted therapy in #ADC
@OncoAlert
@AACR
热度 13 · 8 赞 · 0 回复 · 5 转发
会议摘要
6741按 药名 pertuzumab 对上
Tertiary lymphoid structure (TLS)-associated immune circuits define response to durvalumab, trastuzumab, and pertuzumab (DTP) in HER2-enriched early breast cancerMailin Li, Xen Ping Hoi, Jenying Deng, Junjun Zheng, Rabia Hashmani, Recep Bayraktar, Wei Qian, Jianying Zhou, Jian Guan, Kai Sun, Hanh Mai, Tiffany Sheu, Susan Haley, Mary Schwartz, Sunil Mathur, Stephen T. Wong, Fotis Nikolo, Keith Syson Chan, Polly Niravath, Jenny C. Chang
读摘要原文 →来源：Oriol Mirallas MD · x.com